Merck Targets Experts In Next Fosamax Bellwether

Law360, New York (October 12, 2010, 6:45 PM EDT) -- Fresh off a victory in another case over Fosamax, lawyers for plaintiff Judith Graves on Tuesday battled Merck & Co. Inc.'s efforts to prevent her physicians from testifying at a possible trial that the osteoporosis drug caused a bone-rotting condition in her jaw.

Attorney Timothy M. O’Brien, of Levin Papantonio Thomas Mitchell Echsner Rafferty & Proctor PA, who also handled the winning case for plaintiff Shirley Boles, told a judge in the U.S. District Court for the Southern District of New York that the doctors’ testimony...
To view the full article, register now.



Case Information

Case Title

Graves v. Merck & Co., Inc.

Case Number



New York Southern

Nature of Suit

Personal Inj. Prod. Liability


John F. Keenan

Date Filed

July 21, 2006

Law Firms


Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.